First patients begin gene therapy treatment for blindness as part of NHS Long Term Plan

Babies born with an inherited retinal disorder, known as Leber’s Congenital Amaurosis (LCA), will have access to the new treatment voretigene neparvovec, a new generation of gene therapies that can be directly administered to patients.

Source:

NHS England